Literature DB >> 17701750

The XRCC3 Thr241Met polymorphism and breast cancer risk: a case-control study in a Thai population.

Suleeporn Sangrajrang1, Peter Schmezer, Iris Burkholder, Paolo Boffetta, Paul Brennan, Andreas Woelfelschneider, Helmut Bartsch, Surapon Wiangnon, Arkom Cheisilpa, Odilia Popanda.   

Abstract

The X-ray repair cross-complementing group 3 gene (XRCC3) belongs to a family of genes responsible for repairing DNA double-strand breaks caused by normal metabolic processes and exposure to ionizing radiation. Polymorphisms in DNA repair genes may alter an individual's capacity to repair damaged DNA and may lead to genetic instability and contribute to malignant transformation. We examined the role of a polymorphism in the XRCC3 gene (rs861529; codon 241: threonine to methionine change) in determining breast cancer risk in Thai women. The study population consisted of 507 breast cancer cases and 425 healthy women. The polymorphism was analysed by fluorescence-based melting curve analysis. The XRCC3 241Met allele was found to be uncommon in the Thai population (frequency 0.07 among cases and 0.05 among controls). Odds ratios (OR) adjusted for age, body mass index, age at menarche, family history of breast cancer, menopausal status, reproduction parameters, use of contraceptives, tobacco smoking, involuntary tobacco smoking, alcohol drinking, and education were calculated for the entire population as well as for pre- and postmenopausal women. There was a significant association between 241Met carrier status and breast cancer risk (OR 1.58, 95% confidence interval (CI) 1.02-2.44). Among postmenopausal women, a slightly higher OR (1.82, 95% CI 0.95-3.51) was found than among premenopausal women (OR 1.48, 95% CI 0.82-2.69). Our findings suggest that the XRCC3 Thr241Met polymorphism is likely to play a modifying role in the individual susceptibility to breast cancer among Thai women as already shown for women of European ancestry.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701750     DOI: 10.1080/13547500701395602

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  14 in total

1.  Association between the XRCC3 polymorphisms and breast cancer risk: meta-analysis based on case-control studies.

Authors:  Xiao-Feng He; Wu Wei; Jiao Su; Zi-Xuan Yang; Yi Liu; Ying Zhang; Da-Peng Ding; Wei Wang
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

2.  FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.

Authors:  Miriam S Udler; Kerstin B Meyer; Karen A Pooley; Eric Karlins; Jeffery P Struewing; Jinghui Zhang; David R Doody; Stewart MacArthur; Jonathan Tyrer; Paul D Pharoah; Robert Luben; Leslie Bernstein; Laurence N Kolonel; Brian E Henderson; Loic Le Marchand; Giske Ursin; Michael F Press; Paul Brennan; Suleeporn Sangrajrang; Valerie Gaborieau; Fabrice Odefrey; Chen-Yang Shen; Pei-Ei Wu; Hui-Chun Wang; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Bruce A J Ponder; Christopher A Haiman; Kathleen E Malone; Alison M Dunning; Elaine A Ostrander; Douglas F Easton
Journal:  Hum Mol Genet       Date:  2009-02-17       Impact factor: 6.150

3.  Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study.

Authors:  Alexandra S Shadrina; Natalia A Ermolenko; Uljana A Boyarskikh; Tatiana V Sinkina; Alexandr F Lazarev; Valentina D Petrova; Maxim L Filipenko
Journal:  Clin Exp Med       Date:  2014-12-24       Impact factor: 3.984

4.  New single nucleotide polymorphisms (SNPs) in homologous recombination repair genes detected by microarray analysis in Polish breast cancer patients.

Authors:  Hanna Romanowicz; Dominik Strapagiel; Marcin Słomka; Marta Sobalska-Kwapis; Ewa Kępka; Anna Siewierska-Górska; Marek Zadrożny; Jan Bieńkiewicz; Beata Smolarz
Journal:  Clin Exp Med       Date:  2016-11-30       Impact factor: 3.984

5.  Analysis of DNA Repair Genes Polymorphisms in Breast Cancer.

Authors:  Hanna Romanowicz; Łukasz Pyziak; Filip Jabłoński; Magdalena Bryś; Ewa Forma; Beata Smolarz
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

6.  Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Authors:  Sean V Tavtigian; Peter J Oefner; Davit Babikyan; Anne Hartmann; Sue Healey; Florence Le Calvez-Kelm; Fabienne Lesueur; Graham B Byrnes; Shu-Chun Chuang; Nathalie Forey; Corinna Feuchtinger; Lydie Gioia; Janet Hall; Mia Hashibe; Barbara Herte; Sandrine McKay-Chopin; Alun Thomas; Maxime P Vallée; Catherine Voegele; Penelope M Webb; David C Whiteman; Suleeporn Sangrajrang; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2009-09-24       Impact factor: 11.025

7.  Breast cancer in the Thai Cohort Study: an exploratory case-control analysis.

Authors:  Susan Jordan; Lynette Lim; Duangkae Vilainerun; Emily Banks; Nintita Sripaiboonkij; Sam-ang Seubsman; Adrian Sleigh; Christopher Bain
Journal:  Breast       Date:  2009-10-02       Impact factor: 4.380

8.  Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.

Authors:  Karin Broberg; Elizabeth Huynh; Karin Schläwicke Engström; Jonas Björk; Maria Albin; Christian Ingvar; Håkan Olsson; Mattias Höglund
Journal:  BMC Cancer       Date:  2009-05-11       Impact factor: 4.430

9.  Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women.

Authors:  Beata Smolarz; Marianna Makowska; Dariusz Samulak; Magdalena M Michalska; Ewa Mojs; Maciej Wilczak; Hanna Romanowicz
Journal:  Clin Exp Med       Date:  2014-04-13       Impact factor: 3.984

10.  The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women.

Authors:  Peijian Ding; Yang Yang; Luyang Cheng; Xuejun Zhang; Limin Cheng; Caizhen Li; Jianhui Cai
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.